Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Novartis AG (NYSE: NVS) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Novartis AG (NYSE: NVS) concerning whether a series of statements by Novartis AG regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On August 6, 2019, the U.S. Food and Drug Administration (“FDA”) issued a statement revealing that data submitted in the Company’s biologics license application (“BLA”) for its gene therapy drug, Zolgensma, had been manipulated. Furthermore, it stated that the Company “became aware of the issue of the data manipulation that created inaccuracies in their BLA before the FDA approved the product, yet did not inform the FDA until after the product was approved.” Novartis is currently being investigated by the FDA and may be subject to further penalties.

Following this news, NYSE: NVS fell $2.50 per share, or nearly 3%, to close at $88.22 on August 6, 2019.

Based in Basel, Switzerland, and founded in 1895 Novartis AG researches, develops, manufactures, and markets healthcare products worldwide.

If you purchased shares of Novartis AG (NYSE: NVS) on or before August 6, 2019, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Materials are provided for informational purposes only and do not constitute legal advice. We are only licensed to practice law in Germany. We are neither licensed nor qualified to render advice on US Federal or State law.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185